Thomas Thevenet
Impact in
- Neurology top 10%
- Neuroblastoma Research and Treatments
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 5
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 1
-
- Neuroblastoma Research and Treatments 4
- Co-authors
- Kjell Öberg (1 shared paper)Philippe Ruszniewski (1 shared paper)Timothy J. Hobday (1 shared paper)Andrew Hendifar (1 shared paper)Jonathan Strosberg (1 shared paper)Beth Chasen (1 shared paper)Matthew H. Kulke (1 shared paper)Martyn Caplin (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Dermatological Science (1 paper)Annals of Oncology (1 paper)Endocrine Abstracts (2 papers)PubMed (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Thomas Thevenet
6 papers receiving 294 citations
Thomas Thevenet's Hit Papers
Peers
Comparison fields: 5 of 41
- Neurology 117
- Epidemiology 228
- Oncology 161
- Radiology, Nuclear Medicine and Imaging 65
- Pulmonary and Respiratory Medicine 20
Countries citing papers authored by Thomas Thevenet
This map shows the geographic impact of Thomas Thevenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Thevenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Thevenet more than expected).
Fields of papers citing papers by Thomas Thevenet
This network shows the impact of papers produced by Thomas Thevenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Thevenet. The network helps show where Thomas Thevenet may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Thevenet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial Hit paper breakdown → | 2018 | 277 |
| 2 | 2017 | 12 | |
| 3 | Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumors. | 1978 | 3 |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 0 |
About Thomas Thevenet
Thomas Thevenet is a scholar working on Oncology, Neurology, Epidemiology, Dermatology and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 295 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Neuroblastoma Research and Treatments (4 papers), Radiopharmaceutical Chemistry and Applications (1 paper), Alkaloids: synthesis and pharmacology (1 paper), Medical Imaging Techniques and Applications (1 paper), Cancer Treatment and Pharmacology (1 paper) and Plant-based Medicinal Research (1 paper). The work is most often cited by research in Neurology (117 citations), Epidemiology (228 citations), Oncology (161 citations), Radiology, Nuclear Medicine and Imaging (65 citations) and Pulmonary and Respiratory Medicine (20 citations). Thomas Thevenet has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Kjell Öberg, Philippe Ruszniewski, Timothy J. Hobday, Andrew Hendifar, Jonathan Strosberg, Beth Chasen, Matthew H. Kulke, Martyn Caplin, Edward M. Wolin and Eric P. Krenning. Their work appears in journals such as Journal of Clinical Oncology, Journal of Dermatological Science, Annals of Oncology, Endocrine Abstracts and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.